Participation is voluntary and is preceded by written informed consent. Treatment will be terminated in cases of unacceptable side effects, or upon patient's request at any time. If a patient is not interested in participation in the trial, treatment will be given according to the department's usual guidelines. The study is therefore considered ethically sound.